# Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)

> **NCT03828942** · — · COMPLETED · sponsor: **Groupe Hospitalier Pitie-Salpetriere** · enrollment: 1000 (actual)

## Conditions studied

- Hematological Abnormality
- Hematotoxicity

## Interventions

- **DRUG:** drug inducing hematological toxicity

## Key facts

- **NCT ID:** NCT03828942
- **Lead sponsor:** Groupe Hospitalier Pitie-Salpetriere
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2023-04-08
- **Target enrollment:** 1000 (ACTUAL)
- **Last updated:** 2023-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03828942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03828942, "Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT03828942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*